#biotechnology
6 articles
Pharma & Biotech
Cellectis Eyes 2028 FDA Filing for Lasme-cel as Cash Runway Extends to Mid-2027
ViaNews Editorial Team (Finance)•
Analysis
Four Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near Market
ViaNews Editorial Team (Finance)•
Analysis
Major Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA Approvals
ViaNews Editorial Team (Finance)•
Analysis
NVIDIA Targets Drug Discovery Market With AI Infrastructure Push
ViaNews Editorial Team (Finance)•